Our "insight" early data release at ASCO will be of interest to many....Avelumab has a rap sheet
as long as your arm in regard to side effects but it has approval due to scarcity of other treatments
available...Very small trial and wont effect the market in my mind but we will see....
Ann: INSIGHT-004 and TACTI-002 data to be presented at ASCO, page-14
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
-0.020(6.25%) |
Mkt cap ! $435.7M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.5¢ | 29.5¢ | $2.355M | 7.796M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 128197 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |